Jacob Sten Petersen, Novo Nordisk head of global research
May 19, 2026 11:22 AM EDT
PeopleR&D
Q&A: Novo Nordisk research chief discusses streamlined R&D, asset integration and role of AI
Elizabeth Cairns
Novo Nordisk's global research head Jacob Sten Petersen discusses post-reorganization R&D strategy, pipeline diversification beyond semaglutide, and AI's role in drug discovery.
Jacob Sten Petersen, Novo Nordisk head of global research
May 19, 2026 11:22 AM EDT
PeopleR&D
Q&A: Novo Nordisk research chief discusses streamlined R&D, asset integration and role of AI
Elizabeth Cairns

The partnership will enable Novo to better use AI to analyze complex datasets, and identify promising new drugs.

CNBC's Charlotte Reed will travel to Copenhagen to speak with Novo Nordisk's new CEO after a bumpy few months.

Jorgensen, who joined in 2017, has had the shortest tenure of all. Danish couple August and Marie Krogh founded Nordsik…

Novo Nordisk is leveraging Artificial Intelligence to significantly speed up new drug launches. The company expects to cut down…

Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…

Mike Doustdar setzt alles daran, den Konzern im Rennen gegen US-Rivalen Eli Lilly wieder nach vorn zu bringen. Ein Mann mit einer…